Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2016 Q2- Text added to 2016 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
abemaciclib, Astra, begun, Cardero, CDK, effort, EGFR, fact, futility, Innocrin, member, palbociclib, pharmacokinetic, RAD, ribociclib, stopped, Taselisib, VT, Zeneca
Removed:
commit, determining, diminished, platinum, taxane
Valuein 2016 Q2 filing- Value in 2016 Q3 filing
Original filings
Filing view